BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun XL, Chen SY, Tao SS, Qiao LC, Chen HJ, Yang BL. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World J Gastroenterol 2020; 26(14): 1554-1563 [PMID: 32327905 DOI: 10.3748/wjg.v26.i14.1554]
URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1554.htm
Number Citing Articles
1
Brindusa Truta. Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right placeWorld Journal of Gastroenterology 2022; 28(13): 1380-1383 doi: 10.3748/wjg.v28.i13.1380
2
Jeroen Geldof, Nusrat Iqbal, Janindra Warusavitarne, Ailsa Hart. The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel Diseases: Combined Medical-Surgical Treatment in Complex Perianal Fistulas in CDClinics in Colon and Rectal Surgery 2022; 35(01): 021 doi: 10.1055/s-0041-1740035
3
Feihong Deng, Pianpian Xia, Zengrong Wu, Hejun Zhou, Xuehong Wang. Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s DiseaseInternational Journal of General Medicine 2021; : 3387 doi: 10.2147/IJGM.S315505